{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T04:35:58Z","timestamp":1762662958615,"version":"build-2065373602"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":101,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Arboviral arthritides are a group of viral infections affecting the musculoskeletal system. Mosquitoes are vectors for some of the arboviral febrile diseases such as due to chikungunya, dengue and Zika viruses, which constitute a major proportion of arboviral arthritide syndromes in humans. They have gained epidemiological importance as the natural habitats of these mosquitoes are in the vicinity of human dwellings. Chikungunya virus infection frequently leads to post-infectious chronic musculoskeletal syndromes including erosive inflammatory arthritis, which resembles RA. Clinical features of the chronic phase result from the chronic persistence of the virus in certain tissues after the acute infection has resolved. In addition, the triggering of autoimmunity has also been implicated in musculoskeletal syndromes. Due to the diversity of clinical presentations and overlapping features with other viral illnesses and inflammatory arthritides, diagnosis and management are challenging. Poor prognostic factors for predicting evolution to chronic arthritides are not well delineated. There is no universal agreement regarding when to start immunomodulatory agents and the duration of such therapy. The lack of specific antiviral agents adds to the complexity of the situation. A live-attenuated vaccine has been recently approved by the US Food and Drug Administration for the prevention of chikungunya virus infection. This review discusses the musculoskeletal syndromes related to arboviral infections, with a major focus on chikungunya virus\u2013related arthritis to provide practical guidance to clinicians involved in managing patients with chikungunya and its sequelae.<\/jats:p>","DOI":"10.1093\/rap\/rkaf029","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T23:49:40Z","timestamp":1741304980000},"source":"Crossref","is-referenced-by-count":0,"title":["Current and future advances in practice: arboviral arthritides"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4810-8921","authenticated-orcid":false,"given":"Ashish","family":"Sharma","sequence":"first","affiliation":[{"name":"Dilshad Garden, Rheumatology Clinic , New Delhi,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5842-1877","authenticated-orcid":false,"given":"Vinod","family":"Ravindran","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre for Rheumatology , Calicut, Kerala,","place":["India"]},{"name":"Department of Medicine, Kasturba Medical College, Manipal Academy of Higher Education , Manipal, Karnataka,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"2025110823315675500_rkaf029-B1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/B978-0-7020-4089-4.00066-4","volume-title":"Medical microbiology","author":"Barrett","year":"2012","edition":"18th edn."},{"key":"2025110823315675500_rkaf029-B2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41572-023-00429-2","article-title":"Chikungunya fever","volume":"9","author":"Bartholomeeusen","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"2025110823315675500_rkaf029-B3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.berh.2015.04.009","article-title":"Infections and arthritis","volume":"28","author":"Mathew","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025110823315675500_rkaf029-B4","doi-asserted-by":"crossref","first-page":"e0012254","DOI":"10.1371\/journal.pntd.0012254","article-title":"Clinical outcomes of chikungunya: a systematic literature review and meta-analysis","volume":"18","author":"Rama","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110823315675500_rkaf029-B5","doi-asserted-by":"crossref","first-page":"105402","DOI":"10.1016\/j.actatropica.2020.105402","article-title":"Characterization of the first autochthonous dengue outbreak in Spain (August\u2013September 2018)","volume":"205","author":"Monge","year":"2020","journal-title":"Acta Trop"},{"key":"2025110823315675500_rkaf029-B6","doi-asserted-by":"crossref","first-page":"e0008250","DOI":"10.1371\/journal.pntd.0008250","article-title":"Assessing entomological risk factors for arboviral disease transmission in the French Territory of the Wallis and Futuna Islands","volume":"14","author":"Calvez","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110823315675500_rkaf029-B7","doi-asserted-by":"crossref","first-page":"e0167025","DOI":"10.1371\/journal.pone.0167025","article-title":"The significance of prolonged and saddleback fever in hospitalised adult dengue","volume":"11","author":"Ng","year":"2016","journal-title":"PLoS One"},{"key":"2025110823315675500_rkaf029-B8","doi-asserted-by":"crossref","first-page":"e200047","DOI":"10.1212\/NXI.0000000000200047","article-title":"Guillain\u2013Barr\u00e9 syndrome following Zika virus infection is associated with a diverse spectrum of peripheral nerve reactive antibodies","volume":"10","author":"Davies","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025110823315675500_rkaf029-B9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2020.01.015","article-title":"Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development","volume":"543","author":"Pielnaa","year":"2020","journal-title":"Virology"},{"key":"2025110823315675500_rkaf029-B10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12941-016-0172-y","article-title":"Management of infection by the Zika virus","volume":"15","author":"Falcao","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025110823315675500_rkaf029-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.ento.47.091201.145100","article-title":"Ross River virus: ecology and distribution","volume":"47","author":"Russell","year":"2002","journal-title":"Annu Rev Entomol"},{"key":"2025110823315675500_rkaf029-B12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.bor.0000130537.76808.26","article-title":"Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses","volume":"16","author":"Suhrbier","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"2025110823315675500_rkaf029-B13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12929-021-00778-8","article-title":"Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries","volume":"28","author":"Khongwichit","year":"2021","journal-title":"J Biomed Sci"},{"key":"2025110823315675500_rkaf029-B14","doi-asserted-by":"crossref","first-page":"e0009337","DOI":"10.1371\/journal.pntd.0009337","article-title":"The worldwide seroprevalence of DENV, CHIKV and ZIKV infection: a systematic review and meta-analysis","volume":"15","author":"Li","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110823315675500_rkaf029-B15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1473-3099(23)00810-1","article-title":"Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study","volume":"24","author":"Kang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025110823315675500_rkaf029-B16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/tropicalmed8060301","article-title":"Epidemiology and economic burden of chikungunya: a systematic literature review","volume":"8","author":"Costa","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"2025110823315675500_rkaf029-B17","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/v7072792","article-title":"Early events in chikungunya virus infection-from virus cell binding to membrane fusion","volume":"7","author":"van Duijl-Richter","year":"2015","journal-title":"Viruses"},{"key":"2025110823315675500_rkaf029-B18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.medmal.2015.05.007","article-title":"French guidelines for the management of chikungunya (acute and persistent presentations)","volume":"45","author":"Simon","year":"2015","journal-title":"Med Mal Infect"},{"key":"2025110823315675500_rkaf029-B19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.rbr.2017.05.004","article-title":"Recommendations of the Brazilian Society of Rheumatology for diagnosis and treatment of chikungunya fever. Part 1 \u2013 diagnosis and special situations","volume":"57(Suppl 2)","author":"Marques","year":"2017","journal-title":"Rev Bras Reumatol (Engl Ed)"},{"key":"2025110823315675500_rkaf029-B20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jiq006","article-title":"The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation","volume":"204","author":"Wauquier","year":"2011","journal-title":"J Infect Dis"},{"key":"2025110823315675500_rkaf029-B21","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJM199912303412707","article-title":"Molecular mimicry and autoimmunity","volume":"341","author":"Albert","year":"1999","journal-title":"N Engl J Med"},{"key":"2025110823315675500_rkaf029-B22","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.4049\/jimmunol.0900255","article-title":"Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response","volume":"184","author":"Hoarau","year":"2010","journal-title":"J Immunol"},{"key":"2025110823315675500_rkaf029-B23","first-page":"329","article-title":"Rampant infections of bone marrow stem cell niches as triggers for spondyloarthropathies and rheumatoid arthritis","volume":"34","author":"Berthelot","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2025110823315675500_rkaf029-B24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.40383","article-title":"Chikungunya arthritis mechanisms in the Americas: a cross-sectional analysis of chikungunya arthritis patients twenty-two months after infection demonstrating no detectable viral persistence in synovial fluid","volume":"70","author":"Chang","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2025110823315675500_rkaf029-B25","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3389\/fimmu.2019.01207","article-title":"Evidence for host epigenetic signatures arising from arbovirus infections: a systematic review","volume":"10","author":"de Aguiar","year":"2019","journal-title":"Front Immunol"},{"key":"2025110823315675500_rkaf029-B26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.humimm.2017.02.006","article-title":"Impaired NK cell functionality and increased TNF-\u03b1 production as biomarkers of chronic chikungunya arthritis and rheumatoid arthritis","volume":"78","author":"Thanapati","year":"2017","journal-title":"Hum Immunol"},{"key":"2025110823315675500_rkaf029-B27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.virusres.2013.08.011","article-title":"Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes\/macrophages in CHIKV-induced arthralgia\/arthritis","volume":"177","author":"Phuklia","year":"2013","journal-title":"Virus Res"},{"key":"2025110823315675500_rkaf029-B28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2217\/fvl.15.107","article-title":"The pathogenesis of chronic chikungunya: evolving concepts","volume":"11","author":"Roosenhoff","year":"2016","journal-title":"Future Virol"},{"key":"2025110823315675500_rkaf029-B29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/qjmed\/hcu033","article-title":"Mesenchymal stem cells, autoimmunity and rheumatoid arthritis","volume":"107","author":"El-Jawhari","year":"2014","journal-title":"QJM"},{"key":"2025110823315675500_rkaf029-B30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/art.40403","article-title":"Chikungunya arthritis: implications of acute and chronic inflammation mechanisms on disease management","volume":"70","author":"Zaid","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2025110823315675500_rkaf029-B31","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110823315675500_rkaf029-B32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cyto.2014.11.028","article-title":"Cytokines pre-determined by genetic factors are involved in pathogenesis of Rheumatoid arthritis","volume":"75","author":"Taneja","year":"2015","journal-title":"Cytokine"},{"key":"2025110823315675500_rkaf029-B33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2249.2010.04132.x","article-title":"99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: triggering of autoimmune diseases by infections","volume":"160","author":"Getts","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2025110823315675500_rkaf029-B34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/ard.58.8.454","article-title":"Mechanisms of viral pathogenesis in rheumatic disease","volume":"58","author":"Perl","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"2025110823315675500_rkaf029-B35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7861\/clinmed.2019-0035","article-title":"Chikungunya arthritis","volume":"19","author":"Pathak","year":"2019","journal-title":"Clin Med (Lond)"},{"key":"2025110823315675500_rkaf029-B36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1590\/0004-282x20160138","article-title":"Neurological manifestations of chikungunya and Zika infections","volume":"74","author":"Pinheiro","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"key":"2025110823315675500_rkaf029-B37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.trstmh.2010.01.011","article-title":"Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging","volume":"104","author":"Manimunda","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2025110823315675500_rkaf029-B38","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1002\/art.23753","article-title":"Chikungunya virus aches and pains: an emerging challenge","volume":"58","author":"Chopra","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025110823315675500_rkaf029-B39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0035-9203(55)90080-8","article-title":"An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952\u201353. I. Clinical features","volume":"49","author":"Robinson","year":"1955","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2025110823315675500_rkaf029-B40","doi-asserted-by":"crossref","first-page":"e7603","DOI":"10.1371\/journal.pone.0007603","article-title":"Prospective study of chikungunya virus acute infection in the Island of La R\u00e9union during the 2005\u20132006 outbreak","volume":"4","author":"Staikowsky","year":"2009","journal-title":"PLoS One"},{"key":"2025110823315675500_rkaf029-B41","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.amjmed.2019.10.005","article-title":"Chronic chikungunya arthritis and rheumatoid arthritis: what they have in common","volume":"133","author":"Amaral","year":"2020","journal-title":"Am J Med"},{"key":"2025110823315675500_rkaf029-B42","doi-asserted-by":"crossref","first-page":"639178","DOI":"10.1155\/2012\/639178","article-title":"Epidemiology, clinical manifestations, and long-term outcomes of a major outbreak of chikungunya in a hamlet in Sri Lanka, in 2007: a longitudinal cohort study","volume":"2012","author":"Kularatne","year":"2012","journal-title":"J Trop Med"},{"key":"2025110823315675500_rkaf029-B43","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1017\/S0950268811001300","article-title":"Acute chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study","volume":"140","author":"Chopra","year":"2012","journal-title":"Epidemiol Infect"},{"key":"2025110823315675500_rkaf029-B44","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3899\/jrheum.190162","article-title":"Chronic joint pain 3 years after chikungunya virus infection largely characterized by relapsing-remitting symptoms","volume":"47","author":"Tritsch","year":"2020","journal-title":"J Rheumatol"},{"key":"2025110823315675500_rkaf029-B45","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/acr.22900","article-title":"Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis","volume":"68","author":"Rodr\u00edguez-Morales","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025110823315675500_rkaf029-B46","first-page":"313","article-title":"Chikungunya virus infection. A retrospective study of 107 cases","volume":"63","author":"Brighton","year":"1983","journal-title":"S Afr Med J"},{"key":"2025110823315675500_rkaf029-B47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2334-9-200","article-title":"Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies","volume":"9","author":"Malvy","year":"2009","journal-title":"BMC Infect Dis"},{"key":"2025110823315675500_rkaf029-B48","article-title":"Chikungunya fever outbreak in Brazil: preliminary assessment in a cohort of patients with rheumatological manifestations","volume":"68","author":"Marques","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025110823315675500_rkaf029-B49","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.39775","article-title":"Brief report: management of chronic post-chikungunya rheumatic disease: the Martinican experience","volume":"68","author":"Blettery","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025110823315675500_rkaf029-B50","doi-asserted-by":"crossref","first-page":"e05877","DOI":"10.1002\/ccr3.5877","article-title":"Antisynthetase syndrome after chikungunya infection: a case report","volume":"10","author":"Tu\u00e3o","year":"2022","journal-title":"Clin Case Rep"},{"key":"2025110823315675500_rkaf029-B51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0049475519843781","article-title":"Chikungunya-induced inflammatory myositis: a case report in India","volume":"49","author":"Dev","year":"2019","journal-title":"Trop Doct"},{"key":"2025110823315675500_rkaf029-B52","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMra1406035","article-title":"Chikungunya virus and the global spread of a mosquito-borne disease","volume":"372","author":"Weaver","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110823315675500_rkaf029-B53","doi-asserted-by":"crossref","first-page":"e0855","DOI":"10.1590\/0037-8682-0855-2020","article-title":"Long-term persistence of serum-specific anti-chikungunya IgM antibody\u2014a case series of Brazilian patients","volume":"54","author":"Costa","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"key":"2025110823315675500_rkaf029-B54","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jbspin.2009.08.005","article-title":"A report of 21 cases of rheumatoid arthritis following chikungunya fever. A mean follow-up of two years","volume":"76","author":"Bouquillard","year":"2009","journal-title":"Joint Bone Spine"},{"key":"2025110823315675500_rkaf029-B55","doi-asserted-by":"crossref","first-page":"101672","DOI":"10.1016\/j.eclinm.2022.101672","article-title":"An evaluation of global chikungunya clinical management guidelines: a systematic review","volume":"54","author":"Webb","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2025110823315675500_rkaf029-B56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2010.133488","article-title":"ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials\/epidemiological studies in axial spondyloarthritis","volume":"70","author":"Dougados","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2025110823315675500_rkaf029-B57","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10067-016-3429-0","article-title":"Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study","volume":"36","author":"Ravindran","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2025110823315675500_rkaf029-B58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0973369820080301","article-title":"Methotrexate and hydroxychloroquine combination therapy in chronic chikungunya arthritis: a 16-week study","volume":"3","author":"Pandya","year":"2008","journal-title":"Indian J Rheumatol"},{"key":"2025110823315675500_rkaf029-B59","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4269\/ajtmh.23-0205","article-title":"Therapy for chikungunya arthritis: a study of 133 Brazilian patients","volume":"109","author":"Amaral","year":"2023","journal-title":"Am J Trop Med Hyg"},{"key":"2025110823315675500_rkaf029-B60","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s10067-015-2979-x","article-title":"Chikungunya infection in the general population and in patients with rheumatoid arthritis on biological therapy","volume":"34","author":"Rosario","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2025110823315675500_rkaf029-B61","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet"},{"year":"2023","author":"US Food and Drug Administration","key":"2025110823315675500_rkaf029-B62"},{"key":"2025110823315675500_rkaf029-B63","doi-asserted-by":"crossref","first-page":"eaal1333","DOI":"10.1126\/scitranslmed.aal1333","article-title":"Fingolimod treatment abrogates chikungunya virus-induced arthralgia","volume":"9","author":"Teo","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025110823315675500_rkaf029-B64","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/JVI.02034-14","article-title":"Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection","volume":"89","author":"Chen","year":"2015","journal-title":"J Virol"},{"key":"2025110823315675500_rkaf029-B65","doi-asserted-by":"crossref","first-page":"e0255125","DOI":"10.1371\/journal.pone.0255125","article-title":"Pentosan polysulfate sodium prevents functional decline in chikungunya infected mice by modulating growth factor signalling and lymphocyte activation","volume":"16","author":"Rudd","year":"2021","journal-title":"PLoS One"},{"key":"2025110823315675500_rkaf029-B66","doi-asserted-by":"crossref","first-page":"eaah3438","DOI":"10.1126\/scitranslmed.aah3438","article-title":"Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis","volume":"9","author":"Miner","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025110823315675500_rkaf029-B67","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jmv.21663","article-title":"Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikungunya virus in vitro cells","volume":"82","author":"Khan","year":"2010","journal-title":"J Med Virol"},{"key":"2025110823315675500_rkaf029-B68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12985-016-0607-2","article-title":"Suramin is a potent inhibitor of chikungunya and Ebola virus cell entry","volume":"13","author":"Hen\u00df","year":"2016","journal-title":"Virol J"},{"key":"2025110823315675500_rkaf029-B69","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3855\/T2.2.140","article-title":"Ribavirin therapy for chikungunya arthritis","volume":"2","author":"Ravichandran","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"2025110823315675500_rkaf029-B70","doi-asserted-by":"crossref","first-page":"20122","DOI":"10.1038\/srep20122","article-title":"Inhibition of chikungunya virus replication by 1-[(2-methylbenzimidazol-1-yl) methyl]-2-oxo-indolin-3-ylidene] amino] thiourea (MBZM-N-IBT)","volume":"6","author":"Mishra","year":"2016","journal-title":"Sci Rep"},{"key":"2025110823315675500_rkaf029-B71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2018.10.005","article-title":"Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms","volume":"159","author":"Ho","year":"2018","journal-title":"Antiviral Res"},{"key":"2025110823315675500_rkaf029-B72","doi-asserted-by":"crossref","first-page":"e0007681","DOI":"10.1371\/journal.pntd.0007681","article-title":"Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika virus activity in Aedes aegypti","volume":"13","author":"Dong","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110823315675500_rkaf029-B73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-3542(99)00011-X","article-title":"Guanosine nucleotide analogs as inhibitors of alphavirus mRNA capping enzyme","volume":"42","author":"Lampio","year":"1999","journal-title":"Antiviral Res"},{"key":"2025110823315675500_rkaf029-B74","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.antiviral.2017.06.003","article-title":"Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1","volume":"144","author":"Gigante","year":"2017","journal-title":"Antiviral Res"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/2\/rkaf029\/62918447\/rkaf029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/2\/rkaf029\/62918447\/rkaf029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T04:32:12Z","timestamp":1762662732000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkaf029\/8112035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,14]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkaf029","relation":{},"ISSN":["2514-1775"],"issn-type":[{"type":"electronic","value":"2514-1775"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rkaf029"}}